Brief: Larimar Therapeutics Announces Pricing Of Upsized $100 Million Underwritten Public Offering
Feb 25 (Reuters) - Larimar Therapeutics Inc LRMR.O: LARIMAR THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $100 MILLION UNDERWRITTEN PUBLIC OFFERING LARIMAR THERAPEUTICS INC - PRICES UPSIZED PUBLIC OFFERING AT $5.00 PER SHARE Source text: ID:nGNXzCFqf Further company coverage: LRMR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Larimar Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update